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ABSTRACT
Hybrid closed-loop automated insulin delivery
systems have helped type 1 diabetes (T1D) users
close the loop between glucose monitoring and
insulin delivery, a very important step in efforts
to simulate the glucose-responsive insulin
secretory function of a healthy pancreas. Do-It-
Yourself Artificial Pancreas Systems (DIY APS)
are a form of hybrid closed-loop system that use
open-source algorithms, which govern the
delivery of insulin in response to interstitial
glucose and other variables that are personal-
ized to an individual. The flexibility and cus-
tomization afforded by these systems make
them amenable for use in different worldly cir-
cumstances, one of which is fasting during the
annual occurrence of Ramadan for observant
Muslims. Here, we present the views of a DIY
APS user who was able to fast successfully on
most days of Ramadan after adopting this sys-
tem, and the overview of a physician on these
systems, with a focus on fasting during Rama-
dan with T1D.
Keywords: Artificial pancreas systems; Do-it-
yourself; Hybrid closed-loop systems; Iftaar;
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Observing Ramadan fasting is an
important pillar of faith and hence holds
deep spiritual value for practicing
Muslims. However Type 1 diabetes
patients are risk stratified as being at high
risk, because of the potential for acute
complications and hence advised not to
fast.
In this commentary, a Type 1 diabetes
patient shares her experience of using a
Do-It-Yourself Artificial Pancreas System
(DIY APS), to manage her diabetes during
Ramadan fasting. Her quality of life and
ability to self-manage diabetes were
greatly enhanced by this open source
technology.
DIY APS, a brainchild of the
#WeAreNotWaiting community, has the
flexibility and customizability that are
required for a fasting Type 1 patient;
hence these systems are a therapeutic
option for patients who choose to fast for
religious or personal reasons.
Further research would help regulatory
bodies develop a framework and guidance,
for health care professionals to support
DIY APS users.
A T1D USER PERSPECTIVE
I was diagnosed with type 1 diabetes in early
1996, when I was 8 years old and living in
Pakistan. When I woke up from my diabetic
ketoacidosis (DKA) coma, one of the first things
I was told was a list of the things I would never
be allowed to eat again. All the kids at my
school were told I was contagious, so overnight
I lost any friends I had made with great diffi-
culty as a shy child.
Because of this, management of my type 1
diabetes lay on the periphery of my life for
many years. During my high school years while
living in Kuwait, I suffered from diabulimia. I
did the bare minimum to survive, instead of to
thrive. I moved back to the United States for
university, before joining the US Peace Corps.
This is when I happened to meet my now hus-
band through our matching insulin pumps and
finally had the community and motivation to
take better care of myself. A few years later, our
first daughter, Aiyla, was also diagnosed with
type 1 diabetes when she was 10 months old.
With three T1D patients in our household, I
desperately needed a way to manage all our
blood sugars while also keeping my sanity. We
got my husband the Medtronic MiniMed 670G
system (insurance was not ready for me to
upgrade yet). And then I came across the idea of
the DIY Loop. I decided to try looping because I
needed to focus all my energy on managing our
daughter’s type 1 diabetes and I had noticed
that my good days always correlated with her
bad ones and vice versa.
After some research, I decided on Loop
instead of OpenAPS or AndroidAPS, mainly
because I was already an iPhone user and hap-
pened to have a compatible legacy Medtronic
pump on hand. All I needed was to purchase a
RileyLink, create an Apple Developer account
and download Xcode. It felt like a pretty mini-
mal amount of effort for the potential impact
this software could have on my life. Looping
made it so that my type 1 diabetes took up a lot
less headspace and brainpower for me, while
bringing my HbA1c down to 5.6%. It also gave
me the ability to take care of Aiyla the way I
needed to. It also allowed me to begin practic-
ing a pillar of my faith in a way I had never been
able to before.
All over the world, Muslims celebrate the
month of Ramadan by fasting from dawn until
sunset. A meal is eaten pre-dawn called
‘Suhoor;’ towards the end of a typical fasting
day, when the sun goes down, they break their
fast over the ‘Iftaar’ meal. It is a big milestone
when a child fasts for the first time, and an even
bigger one when they keep the fasts for the
entire month. Most children will try to keep
their first fast between the ages of 7–10. It is not
required until after puberty. It is also not
required of women who are pregnant or nurs-
ing, the elderly and sick. If you are physically
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unable to because of an ailment, you are exempt
from this pillar and are asked to instead feed a
person for every day that you cannot fast or
make a donation to feed the needy.
Ramadan is a very magical time for practic-
ing Muslims, because fasting and keeping away
from our physical needs is a form of spiritual
cleansing. It allows us to focus on prayer, on
charity, on being kind and on the fact that we
are blessed enough to know that at sunset we
will have food and water, whereas so many
poverty-stricken people do not have that lux-
ury. Ramadan is a month of personal reflection
and betterment, a time of community and cel-
ebration. It is a time to remember who and what
are truly important in life.
Because of how old I was at diagnosis, I never
got to experience this big milestone. As a dia-
betic, and with the long days, it can wreak
havoc on our blood sugars to try to fast all day.
Both my husband and I had tried, but we would
end up having to take no insulin for the second
half of the day, only to shock our systems after
the breaking of the fast, which skyrocketed our
blood sugars, keeping them C 16 mmol/l the
rest of the night. We’re pretty sure God does not
want us to hurt our bodies, so we stopped
trying.
Then, last year, after I started looping, I tried
again. And this time, I succeeded far more days
than I did not. I had been looping for a while
and felt like I had my settings pretty dialed in. I
figured it would be like a really good basal test. I
was wrong about that, because your settings
change after changing your routine so drasti-
cally for so long. But I safely kept a little over 20
out of 30 days last year, the rest of them only
being broken by a few skittles or smarties. This
year, I kept closer to 25 out of 30 days thanks to
a deeper understanding of how the Loop works,
and the updates to the system, specifically
around the overrides feature.
Just like last year, it took a while for my body
to adjust to the new routine as far as eating so
early in the morning and eating a big meal later
than normal. Eating that early and that late in
the day was an adjustment for my body, and
figuring out my insulin carbohydrate ratios
(ICRs) for those times took some trial and error.
In the first week of Ramadan, I used a ‘‘Ra-
madan’’ override in Loop with a 30% decrease in
all my settings during the day and another
‘‘Post-Iftaar’’ override with a 140% increase to
prevent the post-Iftaar spike along with a good
20-min pre-bolus. I struggled with going low at
night even though Loop had been cutting off
my insulin for a few hours and I wasn’t entering
in my correction carbohydrates (Fig. 1). I
thought the post-Iftaar override was too
aggressive and catching up with me later at
night, even though it seemed to work fine until
10 p.m. I was also running on the high side in
the morning after Suhoor. I changed a few set-
tings—lowered my insulin sensitivity factor
(ISF) value in those post-Suhoor hours and also
increased my basal.
The second week, I cut out the post-Iftaar
override. I’m pretty sure I was being too
aggressive with the override, which is what was
causing my nighttime lows. Instead, I changed
ICR for the evening by a bit (made that a little
more aggressive) and tried to be really good
about using a pre-bolus for at least 30 min
before Iftaar. The highest I went to was
9.5 mmol/l after Iftaar on the days I wasn’t as
good about pre-bolusing (kids’ bedtimes,
preparing Iftaar, etc.). I would trend in the
6.6–7.2 mmol/l (sometimes going up to 7.7,
which is what I have my high alert set to) for
the first half of the day; then later in the after-
noon, I tend to start to dip a bit but not enough
to make me need to break my fast (Fig. 2).
The third week, I started going low at night
again. So, I dialed back ICR and ISF, so it wasn’t
as aggressive at Iftaar anymore. I started using
the override right after Suhoor; otherwise, I
would go low later (Fig. 3). Pre-bolusing for
Suhoor was difficult as this meant that I would
have to wake up early, which would affect the
duration of my sleep; however, I was usually
trending low at that time in the morning, so it
seemed to work out. I found that the further we
got into Ramadan, the less aggressive I had to be
during mealtimes as my body adjusted to the
new routine.
This last week of Ramadan has been beauti-
ful. I started turning on the automatic bolus
(auto bolus) feature in Loop for post-Iftaar along
with a good pre-bolus before eating. I also
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turned it on during Suhoor and managed not to
bolus manually for Suhoor despite eating about
50 g of carbohydrates in the morning (Fig. 4).
But then I turn off the auto bolus feature during
the rest of the day and went back to my 70%
override. I didn’t need to eat for any of the
times I went down to 3.9 mmol/l because Loop
just brought me back into range perfectly. Many
Muslims have a medium-large meal for Iftaar,
but I learned to break my fast with half a date
and water and say my prayers (which gives my
insulin a chance to kick in) before skipping
right over to dinner. This helps with the post-
Iftaar spike that a lot of diabetics can
experience.
Learning from my experience from the pre-
vious Ramadan, I used a combination of over-
rides and changing settings this year unlike last
year where I only used overrides. I changed my
ISF and ICRs during the new mealtimes because
of the need to be more aggressive, but
thankfully it is easy enough to go back and
adjust those as needed. Basal rates in keeping
with my physiology and requirements range
from 0.9 to 1.25 units/hour. For Ramadan, I
have two different overrides, one that is more
cautious (70%) and the other is 90%. I have my
high alert set to 7.7 mmol/l, and when I see it
climbing above that I either switch to the 80%
override or just turn it off altogether for a bit.
And then if I see I’m trending lower again I just
turn it back on, and it has worked for the most
part.
The advantages to using the DIY Loop while
fasting during Ramadan over the current
and widely used closed-loop Medtronic 670G
system include:
• Being able to use an extremely reliable and
accurate sensor, which is imperative while
fasting. Personal experience with Medtronic
sensors is that at least 20% of the time the
sensor was off by up to 8.5 mmol. With the
Fig. 1 Overview of Saira’s blood sugar readings in the first week of Ramadan: nocturnal dips, due to aggressive post-Iftaar
overrides, and elevations post-Suhoor
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Fig. 2 Overview of Saira’s blood sugar readings in the second week of Ramadan: reduction in nocturnal dips by not using
post-Iftaar override but pre-bolusing 30-min before Iftaar and attenuation of elevations post-Suhoor
Fig. 3 A 12-h snapshot of Saira’s blood sugar readings
between 0200 and 1400 in the third week of Ramadan:
physiologic adaptations cause Saira to drop low again at
night, for which Saira reduced ICR and ISF to give less
insulin for Iftaar; for the post-Suhoor elevations, she used a
gentle override immediately post-Suhoor
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Loop you can choose between any of the
Dexcom sensors, which is pretty accurate,
and I have been using the G6 since it came
out in 2018.
• The ease with which I could customize my
settings both during the day while fasting
and in the evening when I required signifi-
cantly different settings.
• The flexibility to change those settings and
the override recommendations as needed
through the course of Ramadan, as detailed
above. The Medtronic 670G offered limited
overrides like its exercise mode, which
essentially makes it more conservative. How-
ever, it does not last long, and you do not
really get to set it according to what works
for you as easily as you can change settings
with Loop with emerging trends. Medtronic
has a slower learning curve, which in a short-
defined period of 29/30 days is not ideal;
each week can be different as the body
adapts itself to a different routine. There is
a lack of customizability, which makes it
impossible to dial in settings, with different
settings each week of the month.
I am grateful to the developers of DIY APS,
and I am amazed at the rate at which these
systems are evolving, thanks to the enthusiasm
of the members of #WeAreNotWaiting com-
munity. The system has allowed me and other
T1D Muslim patients I know to fast during the
month of Ramadan. The benefits are many, and
I hope that, in the not-so-distant future, this
technology will be regulated and approved for
medical use so that health care specialists can
recommend this as a treatment option for T1
patients.
PHYSICIAN PERSPECTIVE
Fasting in the Islamic month of Ramadan is
obligatory for all sane, healthy adult Muslims.
The length of the day varies significantly in
Fig. 4 Overview of Saira’s blood sugar readings in the fourth week of Ramadan: further physiologic adaptations occur, with
Saira now using a combination of pre-bolus and auto bolus for Iftaar and simply auto bolus for Suhoor
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temperate regions—typically lasting C 18 h
during peak summer in the UK. The synodic
nature of the Islamic calendar means that
Ramadan migrates through all four seasons over
a * 33-year cycle. Despite valid exemptions,
there is an intense desire to fast during this
month even among those who are considered
high risk including many individuals with dia-
betes mellitus.
Diabetes patients wishing to observe the fast
are advised to attend a pre-Ramadan assessment
with their health care providers (HCPs) at least
6–12 weeks before the start of Ramadan [1]. The
International Diabetes Federation and the Dia-
betes and Ramadan International Alliance (IDF-
DAR) Practical Guidelines adopt a three-tiered
risk stratification matrix, with patients stratified
to the very high- or high-risk groups being
advised not to fast and remain a well-accepted
stratification that can be applied for people with
diabetes prior to Ramadan fasting (Table 1) [2].
The guidance highlights the general consensus
among religious authorities and scholars that if
an individual is considered at high to very high
risk then they should refrain from fasting [3].
Factors to be taken into consideration during the
assessment for the purpose of risk stratification
are type of diabetes, ongoing diabetes treatment,
degree of diabetes control, individual propensity
for hypoglycemia, competence at self-manage-
ment, previous Ramadan experience, presence of
diabetes complications and comorbidities,
ongoing or recent intercurrent illness, degree of
frailty, level of cognition, polypharmacy burden,
occupation and social circumstances [1]. Dia-
betes patients can be risk stratified from low,
medium to high or very high risk during the pre-
Ramadan assessment and counseled accord-
ingly. Those who are high to very high risk are
advised not to fast. The current COVID-19 pan-
demic upgrades those in the high-risk category
to very high risk; hence, a significant number of
diabetes patientsmay fall under the penumbra of
the ‘not-to-fast’ advisory [4].
Well-controlled and poorly controlled T1
diabetes patients come under the high-risk and
the very high-risk category, respectively, and are
advised not to fast. However, if the patient
makes an informed decision to fast, an indi-
vidualized management plan should be
developed and they should be supported in the
management of their diabetes [1]. The acute
challenges that fasting T1 patients (and T2
patients on insulin) face are the hyperglycemia
associated with the two meals, i.e., Suhoor and
Iftaar, the hypoglycemia during the fast and the
potential for hypoglycemia due to aggressive
bolusing for meals or from overcorrection of
post-meal spikes.
In T1 diabetes patients, while fasting has
been shown to be feasible in patients on sub-
cutaneous (SC) insulin therapy [5], continuous
subcutaneous insulin infusion (CSII) via insulin
pumps offers the advantage of allowing a mea-
sured delivery of insulin in basal or bolus forms,
which can be tailored to different situations of
the user. e.g., fasting, work, exercise, etc.
A few of the earliest reported experiences of
T1 diabetes patients fasting on CSII therapy
have shown that fasting is feasible with ade-
quate counseling, education and support [5, 6],
without significant adverse events. A multicen-
ter study comparing CSII with multiple-dose
insulin (MDI) showed no difference in the rates
of severe hypoglycemia, glycemic control or the
number of days patients had to be stopped
fasting for extreme dysglycemia [7]. There was
no ketoacidosis reported, and glycemic vari-
ability was better in the CSII group. A systematic
review comparing CSII with multiple daily
injections (MDI)/premixed insulin regimens has
shown lower rates of severe hypoglycemia and
hyperglycemia/ketosis with CSII [8].
The use of continuous glucose monitoring
(CGM) [9–11] or flash glucose monitoring
(FGM) [11, 12] along with pre-Ramadan struc-
tured education can enhance the advantages
offered by CSII in diabetes management during
Ramadan fasting, helping observants fast suc-
cessfully and safely.
Using the low-glucose suspend function in
CSII systems can further improve the safety of
fasting in adolescents and young adults [13].
Hybrid-closed loop systems offer further
potential in improving safety and improved
glycemic outcomes by linking CGM and CSII by
an algorithm that automates insulin delivery
[14, 15].
Do-it-yourself (DIY) closed-loop systems or
DIY artificial pancreas systems (APS) are
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Table 1 Adapted International Diabetes Federation and the Diabetes and Ramadan International Alliance (IDF-DAR) risk
categories and recommendations for patients with diabetes who fast during Ramadan
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unregulated hybrid closed-loop systems that use
open-source software to allow a piece of hard-
ware called the ‘‘rig,’’ which is generally a
computing microprocessor, to communicate
information via a radio stick, such as Saira’s
RileyLink (Fig. 5), to and from a pump and also
communicate with the CGM directly or via a
cloud. The microprocessor collates all the data,
which runs through an algorithm, and decides
how much insulin to give based on the settings
on the pump. Saira’s iPhone with the associated
Loop app is the ‘‘rig’’ in the Loop system.
Evidence for hybrid closed-loop systems
using open-source code is limited to observa-
tional studies, self-reported patient outcomes
and anecdotal reports with a conspicuous lack
of robust clinical trials. Observational data
emphasize the usefulness of this system in
reducing hypoglycemia, glycemic variability,
overnight controls and management burden
with improvement in time in range (TIR),
HbA1c [16, 17] and sleep [16, 18]. A Twitter
analysis of posts from users and carers demon-
strated improvement in HbA1c, glucose vari-
ability, diabetes burden and quality of life [18].
It has been estimated that users can save up to 1
day’s time per month spent making decisions
about diabetes management [19].
There is no current framework that governs
the accountability and responsibility on health
care provision to DIY users. The technology has
not been appraised or approved by regulatory
bodies such as the National Institute of Clinical
Excellence (NICE), Food and Drug Administra-
tion (FDA) and Medicine and Healthcare Prod-
ucts Regulatory Agency (MHRA). While current
DIY APS users have extensive expertise in dia-
betes self-care, as the numbers increase, HCP
may be asked to support individuals who lack a
deeper understanding of the technology [20].
Ramadan is an important annual occurrence
for a practicing Muslim, which has a deep spiri-
tual meaning. Significant dietary and lifestyle
adjustments are required within a short span of
time to observe a fast. The physiologic adapta-
tions that occur as a result can be rigorous,
especially in countries with prolonged fasting
times or extremes of ambient temperatures. In
chronic disease such as diabetes, there is the risk
of maladaptive pathophysiology, which can put
the fasting individual at high risk of morbid-
ity [1]. It is therefore essential for healthcare
professionals and patients to be aware of such
risks and take the necessary precautions to min-
imize them. Hence, we advise a pre-Ramadan
assessment 6–12 weeks before Ramadan [1]. The
flexibility, customization and the spontaneity of
the Loop allowed Saira to use a variety of features
such as overrides, pre-bolus and auto-bolus to
combat the challenges of hyperglycemia and
hypoglycemia described above. Hopefully, she
will use the learning from this year (2020) to fast
with a better average TIR in future Ramadans for
as many days as she wishes.
Fig. 5 The encased RileyLink next to a US quarter for size reference. The RileyLink bridges Bluetooth Low Energy from
the phone to the radiofrequency of the pump and vice versa
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The Medtronic MiniMed 780G system, an
automated insulin delivery system, which
secured the CE marking in June 2020 (awaits a
commercial launch), has added features, among
which the ability to adjust the target setting to
as low as 5.5 mmol/l and Bluetooth connectiv-
ity with compatible iOS and Android systems,
are prominent [21]. This and other sophisti-
cated systems on the horizon for which clinical
trials are underway may parallel the flexibility
and customizability of DIY APS, and thus have
the potential to serve as medically approved
and regulated alternatives for those who wish to
fast.
T1 diabetes patients may want to fast for
personal, health or religious reasons. Technol-
ogy has facilitated T1 diabetes patients’ ability
to self-manage their diabetes while minimizing
the risk of harm; the automation of glucose
sensing and insulin delivery by current systems
provides an opportunity to explore and for-
mally research the prospect of fasting in T1
diabetes. Besides Saira, there are other unpub-
lished accounts of DIY APS users who have
managed to fast safely and satisfactorily for
religious reasons (such as Ramadan) and for
personal or health reasons. Although as
healthcare professionals we are not legally
obliged or insured to recommend these systems,
we should support patients using this technol-
ogy during fasting (and at other times) to make
their fasting experience safe and positively
memorable. The use of DIY APS hybrid closed-
loop systems continues to grow in popularity
with patients and their families. It is vital that
HCPs have some understanding of these sys-
tems and are able to discuss possible risks and
benefits with their patients and support them
where this is feasible.
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